BOTANICAL ELIXIR LTD

Company Registration Number:
15043080 (England and Wales)

Unaudited abridged accounts for the year ended 31 August 2025

Period of accounts

Start date: 01 September 2024

End date: 31 August 2025

BOTANICAL ELIXIR LTD

Contents of the Financial Statements

for the Period Ended 31 August 2025

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

BOTANICAL ELIXIR LTD

Company Information

for the Period Ended 31 August 2025




Director: Laura McSeveney-Sprague
Damon Gollino
Registered office: 1
Belle Vue Terrace
Lincoln
England
LN1 1HQ
Company Registration Number: 15043080 (England and Wales)

BOTANICAL ELIXIR LTD

Balance sheet

As at 31 August 2025


Notes

2025
£
13 months to
31 Aug 2024
£
Fixed assets
Tangible assets: 4 2,500 2,839
Total fixed assets: 2,500 2,839
Current assets
Stocks: 5,045 6,021
Cash at bank and in hand: 715
Total current assets: 5,760 6,021
Net current assets (liabilities): 5,760 6,021
Total assets less current liabilities: 8,260 8,860
Provision for liabilities: ( 37,260 )
Total net assets (liabilities): 8,260 ( 28,400 )

The notes form part of these financial statements

BOTANICAL ELIXIR LTD

Balance sheet continued

As at 31 August 2025


Notes

2025
£
13 months to
31 Aug 2024
£
Capital and reserves
Called up share capital: 100 100
Revaluation reserve: 5 ( 339 )
Profit and loss account: 8,499 ( 28,500 )
Shareholders funds: 8,260 ( 28,400 )

For the year ending 31 August 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 1 September 2025
And Signed On Behalf Of The Board By:

Name: Laura McSeveney-Sprague
Status: Director

The notes form part of these financial statements

BOTANICAL ELIXIR LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BOTANICAL ELIXIR LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

  • 2. Employees


    2025
    13 months to
    31 Aug 2024
    Average number of employees during the period 0 0

BOTANICAL ELIXIR LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

  • 3. Off balance sheet disclosure

    No

BOTANICAL ELIXIR LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

4. Tangible Assets

Total
Cost £
At 01 September 2024 2,839
Additions -
Disposals -
Revaluations (339)
Transfers -
At 31 August 2025 2,500
Depreciation
At 01 September 2024 -
Charge for year -
On disposals -
Other adjustments -
At 31 August 2025 -
Net book value
At 31 August 2025 2,500
At 31 August 2024 2,839

BOTANICAL ELIXIR LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

5. Revaluation reserve


2025
£
Surplus or deficit after revaluation ( 339 )
Balance at 31 August 2025 ( 339 )